应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01558 东阳光长江药业
未开盘 12-19 16:08:47
9.810
-0.630
-6.03%
最高
10.400
最低
9.740
成交量
474.00万
今开
10.400
昨收
10.440
日振幅
6.32%
总市值
86.32亿
流通市值
64.16亿
总股本
8.80亿
成交额
4,734万
换手率
0.72%
流通股本
6.54亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
东阳光长江药业(01558)下跌5.27%,报9.89元/股
金融界 · 12-19 13:13
东阳光长江药业(01558)下跌5.27%,报9.89元/股
港股指南 | 东阳光药:单品依赖的“抗流感神药”神话破灭,转型之路荆棘密布
中金在线 · 12-19 11:19
港股指南 | 东阳光药:单品依赖的“抗流感神药”神话破灭,转型之路荆棘密布
东阳光长江药业12月16日获南向资金加仓420.32万股
市场透视 · 12-17 09:30
东阳光长江药业12月16日获南向资金加仓420.32万股
南向资金12月13日净买入东阳光长江药业129.00万股 连续7日增持
市场透视 · 12-16
南向资金12月13日净买入东阳光长江药业129.00万股 连续7日增持
东阳光药冲刺港交所上市:上半年营收、利润双降,张寓帅子承父业
贝多财经 · 12-13
东阳光药冲刺港交所上市:上半年营收、利润双降,张寓帅子承父业
东阳光长江药业12月13日主力资金流入285万元 连续3日加仓
市场透视 · 12-13
东阳光长江药业12月13日主力资金流入285万元 连续3日加仓
医健IPO解码|手握流感“神药”,东阳光药递交港交所上市申请
21世纪经济报道 · 12-13
医健IPO解码|手握流感“神药”,东阳光药递交港交所上市申请
一图解码:东阳光药递表港交所 私有化合并后前景如何?
财华社 · 12-13
一图解码:东阳光药递表港交所 私有化合并后前景如何?
东阳光长江药业12月12日获主力加仓1054万元 环比增加903.81%
市场透视 · 12-12
东阳光长江药业12月12日获主力加仓1054万元 环比增加903.81%
港股异动 | 东阳光长江药业(01558)盘中涨近9% 控股股东东阳光药业递交招股书 拟以介绍方式在港上市
智通财经 · 12-12
港股异动 | 东阳光长江药业(01558)盘中涨近9% 控股股东东阳光药业递交招股书 拟以介绍方式在港上市
东阳光药递交招股书 拟以介绍方式在港上市
美港电讯 · 12-12
东阳光药递交招股书 拟以介绍方式在港上市
东阳光药业拟重组东阳光长江药业并以介绍形式香港上市,递交上市申请
市场资讯 · 12-12
东阳光药业拟重组东阳光长江药业并以介绍形式香港上市,递交上市申请
东阳光长江药业(01558)股价上升8.595%,现价港币$10.36
阿斯达克财经 · 12-12
东阳光长江药业(01558)股价上升8.595%,现价港币$10.36
东阳光长江药业盘中异动 早盘快速上涨5.45%报10.060港元
市场透视 · 12-12
东阳光长江药业盘中异动 早盘快速上涨5.45%报10.060港元
东阳光长江药业(01558)上涨6.08%,报10.12元/股
金融界 · 12-12
东阳光长江药业(01558)上涨6.08%,报10.12元/股
东阳光长江药业12月10日主力资金流出182万元 连续7日减仓
市场透视 · 12-10
东阳光长江药业12月10日主力资金流出182万元 连续7日减仓
南向资金12月9日净买入东阳光长江药业85.92万股 连续3日增持
市场透视 · 12-10
南向资金12月9日净买入东阳光长江药业85.92万股 连续3日增持
东阳光长江药业12月06日遭主力抛售540万元 环比增加282.98%
市场透视 · 12-06
东阳光长江药业12月06日遭主力抛售540万元 环比增加282.98%
东阳光长江药业12月04日遭主力抛售946万元 环比增加450.00%
市场透视 · 12-04
东阳光长江药业12月04日遭主力抛售946万元 环比增加450.00%
东阳光长江药业(01558)出现大手卖出54.74万股,成交价$9.8,涉资536.452万
阿斯达克财经 · 12-04
东阳光长江药业(01558)出现大手卖出54.74万股,成交价$9.8,涉资536.452万
加载更多
公司概况
公司名称:
东阳光长江药业
所属市场:
SEHK
上市日期:
--
主营业务:
宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。其业务还包括药品的研发、营销及分销。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。其核心产品组合包括“可威”、“尔同舒”、“欧美宁”、“欣海宁”及 “喜宁”。
发行价格:
--
{"stockData":{"symbol":"01558","market":"HK","secType":"STK","nameCN":"东阳光长江药业","latestPrice":9.81,"timestamp":1734595727013,"preClose":10.44,"halted":0,"volume":4740000,"delay":0,"floatShares":654000000,"shares":879967700,"eps":2.4290984,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.63,"latestTime":"12-19 16:08:47","open":10.4,"high":10.4,"low":9.74,"amount":47344916,"amplitude":0.063218,"askPrice":9.81,"askSize":2000,"bidPrice":9.8,"bidSize":49000,"shortable":3,"etf":0,"ttmEps":2.0059873096841416,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1451318400000,"adjPreClose":10.44,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.749402,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01558","defaultTab":"news","newsList":[{"id":"2492115988","title":"东阳光长江药业(01558)下跌5.27%,报9.89元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492115988","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492115988?lang=zh_cn&edition=full","pubTime":"2024-12-19 13:13","pubTimestamp":1734585211,"startTime":"0","endTime":"0","summary":"12月19日,东阳光长江药业(01558)盘中下跌5.27%,截至13:13,报9.89元/股,成交2023.29万元。宜昌东阳光长江药业股份有限公司是一家专注于抗病毒、内分泌及代谢性疾病、心血管疾病等治疗领域产品的开发、生产与销售的制药企业,公司产品在中国市场占据重要地位,其中产品磷酸奥司他韦颗粒剂是中国市场唯一的生产商。根据标点医药提供的数据,公司在2014年进入抗流感病毒产品市场前四强,而在2013年和2014年,公司磷酸奥司他韦产品的销量在中国区名列前茅。截至2024年中报,东阳光长江药业营业总收入24.55亿元、净利润6.85亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/19131346576727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01558","BK1515","BK1191"],"gpt_icon":0},{"id":"2492419492","title":"港股指南 | 东阳光药:单品依赖的“抗流感神药”神话破灭,转型之路荆棘密布","url":"https://stock-news.laohu8.com/highlight/detail?id=2492419492","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492419492?lang=zh_cn&edition=full","pubTime":"2024-12-19 11:19","pubTimestamp":1734578371,"startTime":"0","endTime":"0","summary":"2024年12月11日,广东 东阳光 药业股份有限公司正式向香港联交所提交了IPO申请,计划以介绍方式在港上市。面对多方夹击,东阳光药要保持可威的领先地位并不容易。除了可威,东阳光药还在丙型肝炎和乙型肝炎等病毒感染领域取得了进展。完成私有化后,东阳光药将成为一个更加 综合 性的制药集团,具备更强的市场竞争力。然而,东阳光药的转型之路并不平坦,面临着诸多不确定性和挑战。其次,东阳光药的国际化之路","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219112816a1fa2226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219112816a1fa2226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01558","HSTECH","HSCEI","BK1515"],"gpt_icon":1},{"id":"2492748486","title":"东阳光长江药业12月16日获南向资金加仓420.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492748486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492748486?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:30","pubTimestamp":1734399017,"startTime":"0","endTime":"0","summary":"12月16日, 南向资金增持东阳光长江药业420.32万股。截止当日收盘,港股通共持有东阳光长江药业11873.28万股,占流通股18.15%。东阳光长江药业近5个交易日上涨9.46%,港股通累计增持874.20万股;近20个交易日上涨7.05%,港股通累计增持1816.10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093156ab7dbdd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093156ab7dbdd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1515","BK1191"],"gpt_icon":0},{"id":"2491686134","title":"南向资金12月13日净买入东阳光长江药业129.00万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2491686134","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491686134?lang=zh_cn&edition=full","pubTime":"2024-12-16 09:30","pubTimestamp":1734312616,"startTime":"0","endTime":"0","summary":"12月13日, 南向资金增持东阳光长江药业129.00万股,连续7日增持。截止当日收盘,港股通共持有东阳光长江药业11452.96万股,占流通股17.51%。东阳光长江药业近5个交易日上涨7.35%,港股通累计增持539.80万股;近20个交易日上涨5.00%,港股通累计增持1534.20万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093149ab7af999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216093149ab7af999&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2491413773","title":"东阳光药冲刺港交所上市:上半年营收、利润双降,张寓帅子承父业","url":"https://stock-news.laohu8.com/highlight/detail?id=2491413773","media":"贝多财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491413773?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:53","pubTimestamp":1734079988,"startTime":"0","endTime":"0","summary":"12月11日,广东东阳光药业股份有限公司递交招股书,准备在港交所上市,中金公司为其保荐人。据贝多财经了解,东阳光药拟以介绍形式在港交所主板挂牌上市。同时,东阳光药已向港交所申请以介绍方式将H股上市。完成换股后,东阳光长江药业的上市地位将被撤销。具体而言,该公司2024年上半年的营收同比减少20.7%,净利润亦同比下降15.5%。其中,张寓帅为东阳光药非执行董事,郭梅兰为张寓帅的母亲,二者为东阳光药的实际控制人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213171829ab74e30c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213171829ab74e30c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558"],"gpt_icon":0},{"id":"2491343521","title":"东阳光长江药业12月13日主力资金流入285万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491343521","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491343521?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:16","pubTimestamp":1734077760,"startTime":"0","endTime":"0","summary":"12月13日, 东阳光长江药业股价跌0.79%,报收10.08元,成交金额7404万元,换手率1.11%,振幅4.33%,量比1.42。东阳光长江药业今日主力资金净流入285万元,连续3日净流入,上一交易日主力净流入1054万元,今日环比减少72.96%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为60.00%,平均涨幅为3.21%。该股近5个交易日上涨5.86%,主力资金累计净流入827万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出1572万元,其中净流出天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161637a1eb696f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161637a1eb696f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2490592800","title":"医健IPO解码|手握流感“神药”,东阳光药递交港交所上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2490592800","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490592800?lang=zh_cn&edition=full","pubTime":"2024-12-13 11:30","pubTimestamp":1734060616,"startTime":"0","endTime":"0","summary":"在研发队伍上,东阳光药有超过1100名研发人员,截至今年6月30日,其申请2403项发明专利,已获得授权的境内外发明专利共计1351项。根据弗若斯特沙利文报告,以2014年1月1日至2023年12月31日在中国公布的专利数量及授权专利公告数量统计,东阳光药在中国制药公司中排名第一。头豹研究院发布的报告指出,截至2023年年中奥司他韦成分药品占流感用药97.5%的销售份额。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212204211ab726fab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212204211ab726fab&s=b","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":1},{"id":"2491395764","title":"一图解码:东阳光药递表港交所 私有化合并后前景如何?","url":"https://stock-news.laohu8.com/highlight/detail?id=2491395764","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491395764?lang=zh_cn&edition=full","pubTime":"2024-12-13 10:08","pubTimestamp":1734055731,"startTime":"0","endTime":"0","summary":"12月11日,广东东阳光药业股份有限公司(以下简称“东阳光药”)向港交所递交了招股书,计划以介绍方式在港上市;由中金公司担任独家保荐人。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202412_1/b2e775db-7a75-430a-a11a-109bfc79110a.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202412_1/b2e775db-7a75-430a-a11a-109bfc79110a.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/675b974353243c0b5baf2158","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2490987930","title":"东阳光长江药业12月12日获主力加仓1054万元 环比增加903.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490987930","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490987930?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:15","pubTimestamp":1733991328,"startTime":"0","endTime":"0","summary":"12月12日, 东阳光长江药业股价涨6.50%,报收10.16元,成交金额1.38亿元,换手率2.09%,振幅6.08%,量比4.80。东阳光长江药业今日主力资金净流入1054万元,上一交易日主力净流入105万元,今日环比增加903.81%。该股近5个交易日上涨5.61%,主力资金累计净流入2万元;近20日主力资金累计净流出2190万元,其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161541a1e884a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212161541a1e884a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01558","BK1191"],"gpt_icon":0},{"id":"2490737888","title":"港股异动 | 东阳光长江药业(01558)盘中涨近9% 控股股东东阳光药业递交招股书 拟以介绍方式在港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2490737888","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490737888?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:36","pubTimestamp":1733989017,"startTime":"0","endTime":"0","summary":"消息面上,12月11日,东阳光长江药业控股股东东阳光药向港交所递交招股书,拟以介绍方式在港上市。值得注意的是,今年5月10日,东阳光长江药业曾与东阳光药发布联合公告,宣布二者已于当日订立合并协议。完成换股后,东阳光长江药业H股在港交所的上市地位将被撤销,换股股东将成为东阳光药股东,并且东阳光长江药业最终将在中国注销。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1223954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01558","600673","BK0028","BK0070","BK1515","BK1191","BK0188","BK0003","BK0265","BK0012"],"gpt_icon":0},{"id":"2490821726","title":"东阳光药递交招股书 拟以介绍方式在港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2490821726","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490821726?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:44","pubTimestamp":1733982272,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0070","601995","BK1516","BK1564","03908","SG9999002828.SGD","01558","BK0028","BK0012","BK0003","BK0188","BK0276","600673","BK1147","BK1501","BK1515","BK0265","BK1191"],"gpt_icon":0},{"id":"2490822565","title":"东阳光药业拟重组东阳光长江药业并以介绍形式香港上市,递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2490822565","media":"市场资讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490822565?lang=zh_cn&edition=full","pubTime":"2024-12-12 13:39","pubTimestamp":1733981940,"startTime":"0","endTime":"0","summary":"2024年12月11日,广东东阳光药业股份有限公司SUNSHINE LAKE PHARMA CO., LTD.在港交所递交上市申请,拟以介绍形式在香港主板挂牌上市。东阳光药业目前拥有东阳光长江药业的51.41%股权。东阳光药业已提出私有化方案,以吸收合并的方式将东阳光长江药业私有化,将根据换股比率向全体换股股东发行H股,作为换股的对价。完成换股后,东阳光长江药业的上市地位将被撤销。招股书显示,东阳光药业在私有化东阳光药业完成前及上市前的股东架构,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2024-12-12/doc-inczeuyq9750645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","01558","BK1515","BK1191","BK0012","BK0265","BK0028","BK0003","BK0188","600673"],"gpt_icon":0},{"id":"2490970849","title":"东阳光长江药业(01558)股价上升8.595%,现价港币$10.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2490970849","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490970849?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:35","pubTimestamp":1733967300,"startTime":"0","endTime":"0","summary":"[上升股]东阳光长江药业(01558) 股价在上午09:35比前收市价上升8.595%,现股价为港币$10.36。至目前为止,今日最高价为$10.36,而最低价为$9.81。总成交量为290.64万股,总成交金额为港币$2.924千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR24121292/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2490284626","title":"东阳光长江药业盘中异动 早盘快速上涨5.45%报10.060港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490284626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490284626?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:32","pubTimestamp":1733967146,"startTime":"0","endTime":"0","summary":"2024年12月12日早盘09时32分,东阳光长江药业股票出现异动,股价快速上涨5.45%。截至发稿,该股报10.060港元/股,成交量183.8万股,换手率0.28%,振幅3.88%。东阳光长江药业股票所在的药品行业中,整体跌幅为0.12%。其相关个股中,东阳光长江药业、联邦制药、海普瑞涨幅较大,振幅较大的相关个股有东阳光长江药业、联邦制药、中国生物制药,振幅分别为3.88%、3.11%、1.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093226984b70dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093226984b70dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2490846608","title":"东阳光长江药业(01558)上涨6.08%,报10.12元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490846608","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490846608?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:31","pubTimestamp":1733967119,"startTime":"0","endTime":"0","summary":"12月12日,东阳光长江药业(01558)盘中上涨6.08%,截至09:31,报10.12元/股,成交1377.68万元。宜昌东阳光长江药业股份有限公司是一家专注于抗病毒、内分泌及代谢性疾病、心血管疾病等治疗领域产品的开发、生产与销售的制药企业,公司产品在中国市场占据重要地位,其中产品磷酸奥司他韦颗粒剂是中国市场唯一的生产商。根据标点医药提供的数据,公司在2014年进入抗流感病毒产品市场前四强,而在2013年和2014年,公司磷酸奥司他韦产品的销量在中国区名列前茅。截至2024年中报,东阳光长江药业营业总收入24.55亿元、净利润6.85亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/12093146299081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2490664470","title":"东阳光长江药业12月10日主力资金流出182万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490664470","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490664470?lang=zh_cn&edition=full","pubTime":"2024-12-10 16:17","pubTimestamp":1733818626,"startTime":"0","endTime":"0","summary":"12月10日, 东阳光长江药业股价跌0.54%,报收9.25元,成交金额2900万元,换手率0.48%,振幅2.69%,量比0.88。东阳光长江药业今日主力资金净流出182万元,连续7日净流出,上一交易日主力净流出437万元,今日环比减少58.35%。该股近5个交易日下跌4.26%,主力资金累计净流出2244万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出3367万元,其中净流出天数为16日。该股主力净额占比0.03%,港股市场排名2421/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210161803ab6c3221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210161803ab6c3221&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01558","BK1191"],"gpt_icon":0},{"id":"2490397240","title":"南向资金12月9日净买入东阳光长江药业85.92万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2490397240","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490397240?lang=zh_cn&edition=full","pubTime":"2024-12-10 09:30","pubTimestamp":1733794219,"startTime":"0","endTime":"0","summary":"12月9日, 南向资金增持东阳光长江药业85.92万股,连续3日增持。截止当日收盘,港股通共持有东阳光长江药业10999.08万股,占流通股16.81%。港股通增持金额前五个股分别为建设银行、比亚迪电子、速腾聚创、中国海洋石油、工商银行。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093148a1e1edc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093148a1e1edc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1515","BK1191"],"gpt_icon":0},{"id":"2489401432","title":"东阳光长江药业12月06日遭主力抛售540万元 环比增加282.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489401432","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489401432?lang=zh_cn&edition=full","pubTime":"2024-12-06 16:16","pubTimestamp":1733473012,"startTime":"0","endTime":"0","summary":"12月06日, 东阳光长江药业股价跌2.39%,报收9.39元,成交金额2728万元,换手率0.44%,振幅3.64%,量比1.00。东阳光长江药业今日主力资金净流出540万元,连续5日净流出,上一交易日主力净流出141万元,今日环比增加282.98%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为80.00%,平均跌幅为4.14%。该股近5个交易日上涨3.52%,主力资金累计净流出1814万元;近20日主力资金累计净流出2963万元,其中净流出天数为16日。该股主力净额占比0.09%,港股市场排名2613/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161742a1d8a2e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206161742a1d8a2e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2488715938","title":"东阳光长江药业12月04日遭主力抛售946万元 环比增加450.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488715938","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488715938?lang=zh_cn&edition=full","pubTime":"2024-12-04 16:16","pubTimestamp":1733300179,"startTime":"0","endTime":"0","summary":"12月04日, 东阳光长江药业股价涨1.25%,报收9.74元,成交金额2787万元,换手率0.44%,振幅1.87%,量比1.32。东阳光长江药业今日主力资金净流出946万元,连续3日净流出,上一交易日主力净流出172万元,今日环比增加450.00%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为1.65%。该股近5个交易日上涨6.69%,主力资金累计净流出1208万元;近20日主力资金累计净流出2295万元,其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204161649abf500b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204161649abf500b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2488580186","title":"东阳光长江药业(01558)出现大手卖出54.74万股,成交价$9.8,涉资536.452万","url":"https://stock-news.laohu8.com/highlight/detail?id=2488580186","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488580186?lang=zh_cn&edition=full","pubTime":"2024-12-04 10:19","pubTimestamp":1733278740,"startTime":"0","endTime":"0","summary":"[大手成交]东阳光长江药业(01558)在上午10:19出现大手卖出,成交量为54.74万,成交价为港币$9.8,涉资536.452万。至目前为止,股价升1.975%,今日最高价为$9.88,而最低价为$9.7,总成交量为113.98万股,总成交金额港币$1.117千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2412043476/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","01558","BK1515"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hec-changjiang.com","stockEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.0187},{"period":"3month","weight":0.1834},{"period":"6month","weight":0.0864},{"period":"1year","weight":0.0548},{"period":"ytd","weight":0.0337}],"compareEarnings":[{"period":"1week","weight":-0.0316},{"period":"1month","weight":0.0045},{"period":"3month","weight":0.0818},{"period":"6month","weight":0.0956},{"period":"1year","weight":0.1889},{"period":"ytd","weight":0.1587}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。其业务还包括药品的研发、营销及分销。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。其核心产品组合包括“可威”、“尔同舒”、“欧美宁”、“欣海宁”及 “喜宁”。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052152},{"month":2,"riseRate":0.777778,"avgChangeRate":0.088442},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.0661},{"month":4,"riseRate":0.666667,"avgChangeRate":0.018306},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.018369},{"month":6,"riseRate":0.666667,"avgChangeRate":0.070024},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.05594},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.04223},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.045743},{"month":10,"riseRate":0.444444,"avgChangeRate":0.024617},{"month":11,"riseRate":0.777778,"avgChangeRate":0.132165},{"month":12,"riseRate":0.555556,"avgChangeRate":0.014111}],"exchange":"SEHK","name":"东阳光长江药业","nameEN":"HEC CJ PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光长江药业,01558,东阳光长江药业股票,东阳光长江药业股票老虎,东阳光长江药业股票老虎国际,东阳光长江药业行情,东阳光长江药业股票行情,东阳光长江药业股价,东阳光长江药业股市,东阳光长江药业股票价格,东阳光长江药业股票交易,东阳光长江药业股票购买,东阳光长江药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}